IRINEU MASSAIA

Director of Innovation | Leader in Personalized Medicine and Healthcare Innovation | Specialist in Multitasking Management

📍 Brazil🔄 Updated September 2026💼 2 investments📅 7 years investing🗓 Last invested Feb 2021
Operator-angel🌍 Brazil
2
Total investments
1
Early stage
1
Mid stage
0
Late stage
7y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Feb 2021
A Neomed é uma empresa brasileira de tecnologia na saúde com a missão de reduzir a distância entre os sintomas e o tratamento de pacientes. Fundada em 2017, a Neo visa ser a melhor plataforma digital para reduzir a mortalidade por doenças cardiovasculares no mundo, colocando sempre o paciente no centro de todas as decisões. Oferecemos soluções integradas, mirando na jornada digital cardiovascular, atuando desde a promoção e prevenção de doenças, até a gestão e telediagnóstico de exames cardiológicos, apoio diagnóstico e à conduta médica em casos emergenciais. Apostamos na qualidade médica e na ciência somadas à tecnologia de ponta para entregar valor em saúde com soluções voltadas a clínicas, laboratórios, prontos-socorros, hospitais, operadoras de saúde e empresas. Ao longo da nossa jornada, já ajudamos mais de 600 mil vidas e operamos em todo o território nacional. Saiba mais e conheça nossos produtos em neomed.com.br
Private Investor
Feb 2019
Founded in 2019, Alume is a fintech with a mission to provide opportunities for good students to fulfill their dream of becoming doctors, regardless of their financial situation.
Experience · 6 entries
All (6)
Investments (2)
Founder (3)
2025
Partner & Innovation Advisor
Jan 2025
At Health ID, we are revolutionizing capillary blood collection, making diagnostics simpler, faster, and more accessible. Our innovative devices enable high-quality blood sample collection without the need for specialized personnel, ensuring efficiency, reliability, and scalability for laboratories, healthcare providers, and research institutions. Why Choose Health ID? ✅ Pain-Free, Easy-to-Use, Anywhere – Our devices make blood collection stress-free, eliminating the need for conventional venous draws. ✅ No Special Infrastructure Needed – Perfect for clinical trials, epidemiological studies, decentralized diagnostics, and at-home lab testing. ✅ Reliable and Scalable – Validated for hormonal testing, therapeutic drug monitoring, human biomonitoring, and chronic disease management. ✅ Global Expansion Ready – With own manufacturing facilities in Brazil and a monthly production capacity of 100,000 devices, we are ready to scale.
late stagePublic Health
2021
Private Investor
Feb 2021
A Neomed é uma empresa brasileira de tecnologia na saúde com a missão de reduzir a distância entre os sintomas e o tratamento de pacientes. Fundada em 2017, a Neo visa ser a melhor plataforma digital para reduzir a mortalidade por doenças cardiovasculares no mundo, colocando sempre o paciente no centro de todas as decisões. Oferecemos soluções integradas, mirando na jornada digital cardiovascular, atuando desde a promoção e prevenção de doenças, até a gestão e telediagnóstico de exames cardiológicos, apoio diagnóstico e à conduta médica em casos emergenciais. Apostamos na qualidade médica e na ciência somadas à tecnologia de ponta para entregar valor em saúde com soluções voltadas a clínicas, laboratórios, prontos-socorros, hospitais, operadoras de saúde e empresas. Ao longo da nossa jornada, já ajudamos mais de 600 mil vidas e operamos em todo o território nacional. Saiba mais e conheça nossos produtos em neomed.com.br
2019
Co-Founder
Feb 2019
Salú is a healthtech that connects human care and technology to offer complete Occupational Health and Safety (OSH) solutions for your company. Founded in 2021, we take care of more than 150,000 lives in 350 clients, managing 100% of corporate health routine, such as: ➜ Occupational health: ASO, PCMSO, Occupational exams, etc. ➜ Work safety: PGR, CIPA, LTCAT, SIPAT, etc. ➜ Health BI: population health data management ➜ Integration: with other HR systems such as hiring and payroll The solution works like 2 in 1: in addition to HR management system, the Concierge Salú Team handles all day-to-day bureaucracies. We have more than 1,200 clinics throughout Brazil. If any city is missing, Salú registers new partners very quickly! 🚀 Salús management is made up of a team of doctors and engineers who are referenced in the OSH Brazilian market. Clients who trust us: Gupy, XP, Quinto Andar, Neon, C6bank, Flash, olist, CVC, Kopenhagen, save, Recargapay, Loft. Tall to us! #salucomvc 💜
Private Investor
Feb 2019
Founded in 2019, Alume is a fintech with a mission to provide opportunities for good students to fulfill their dream of becoming doctors, regardless of their financial situation.
2018
Founder e Presidente do Conselho
Oct 2018
IonMedicine has used as its primary work instrument metabolomics –a technology that allows for the identification and quantification of metabolites produced by the biological systems– and, through the analysis of post genomics, can express individual’s biochemical phenotype, which is groundbreaking in the way that the approach for health grievances is done. The study of genomics (genes), transcriptomics (mRNA), proteomics (proteins) and metabolomics composes a new technology known as OMICS. Metabolomics differs from the others for it globally evaluates a system’s metabolites (cell, tissue or organism). In this way, it may not only be used for the comprehension of normal physiology, but especially in the better understanding of the metabolic alterations involved in the etiology of illnesses, which allows for metabolomics to become a fundamental tool in medical diagnosis and prognosis.
Show all 6 entries ↓